This week, the FDA granted EUA for two COVID-19 oral antiviral pills, which will be added as a second treatment protocol for COVID-19. Up until now, monoclonal antibodies have been the only authorized treatment for patients with COVID-19.
Read More »Yesterday, the FDA authorized COVID-19 booster shots for 16 and 17 year olds. Young adults in this age group who’ve received two shots of the Pfizer vaccine may now receive a third dose, 6 months after their primary series.
Read More »Last night, the FDA authorized a COVID-19 monoclonal antibody treatment by AstraZeneca for immunocompromised individuals, who did not produce sufficient antibodies following vaccination.
Read More »Last Friday, the FDA authorized the use of Eli Lilly’s monoclonal antibody treatment for young children, including newborns. “Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens, such as viruses.
Read More »